oxybutynin
Selected indexed studies
- Transdermal oxybutynin. (Drugs, 2009) [PMID:19275276]
- Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment. (Urology, 2024) [PMID:38296001]
- Extended-release oxybutynin. (Drugs Aging, 2000) [PMID:10755330]
_Worker-drafted node — pending editorial review._
Connections
oxybutynin is a side effect of
Sources
- Transdermal oxybutynin. (2009) pubmed
- Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment. (2024) pubmed
- Extended-release oxybutynin. (2000) pubmed
- Oxybutynin and the overactive bladder. (2001) pubmed
- Transdermal oxybutynin: a review. (2007) pubmed
- Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis. (2022) pubmed
- Oxybutynin: past, present, and future. (2013) pubmed
- Oxybutynin in detrusor overactivity. (2006) pubmed
- Oxybutynin chloride: alterations in drug delivery and improved therapeutic index. (2002) pubmed
- An Updated Structure of Oxybutynin Hydrochloride. (2024) pubmed